日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1

NFX-179 MEK 抑制剂对 1 型神经纤维瘤病患者的皮肤神经纤维瘤的影响

Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le

Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models

雷帕霉素复合物 1-选择性抑制剂 RMC-6272 在 NF2 缺陷模型中的第三代双空间机制靶点的临床前评估

Srirupa Bhattacharyya, Janet L Oblinger, Roberta L Beauchamp, Lili Kosa, Francis Robert, Scott R Plotkin, Long-Sheng Chang, Vijaya Ramesh

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2

针对患有 2 型神经纤维瘤病的患者的进行性或症状性脑膜瘤进行 mTORC1/2 双重抑制剂 vistusertib 的前瞻性 II 期试验

Justin T Jordan, Christina C Orr, Raquel D Thalheimer, Josephine V Cambillo, Roberta L Beauchamp, Ghalib Shaikh, Alona Muzikansky, Anat Stemmer-Rachamimov, Marco Giovannini, Michel Kalamarides, Fred G Barker 2nd, Vijaya Ramesh, Scott R Plotkin

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

型神经纤维瘤病神经鞘瘤小鼠模型的基因替代治疗

Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, Akiko Yoshinaga, Edwina Abou Haidar, Sevda Lule, Gayathri Mani, Katia Maalouf, Anat Stemmer-Rachamimov, David H Jung, D Bradley Welling, Marco Giovannini, Scott R Plotkin, Casey A Maguire, Vijaya Ramesh, Xandra O Breakefield

Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial

卡博替尼治疗 1 型神经纤维瘤病相关丛状神经纤维瘤:一项 2 期临床试验

Michael J Fisher #, Chie-Schin Shih #, Steven D Rhodes, Amy E Armstrong, Pamela L Wolters, Eva Dombi, Chi Zhang, Steven P Angus, Gary L Johnson, Roger J Packer, Jeffrey C Allen, Nicole J Ullrich, Stewart Goldman, David H Gutmann, Scott R Plotkin, Tena Rosser, Kent A Robertson, Brigitte C Widemann, A

Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma

依维莫司治疗前庭神经鞘瘤或脑膜瘤患者的 0 期临床试验

Matthias A Karajannis, Audrey Mauguen, Ekrem Maloku, Qingwen Xu, Erin M Dunbar, Scott R Plotkin, Anna Yaffee, Shiyang Wang, J Thomas Roland, Chandranath Sen, Dimitris G Placantonakis, John G Golfinos, Jeffrey C Allen, Nicholas A Vitanza, Luis A Chiriboga, Robert J Schneider, Jingjing Deng, Thomas A

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition

mTOR 激酶抑制会破坏神经调节蛋白 1-ERBB3 自分泌信号,并使 NF2 缺陷型脑膜瘤细胞模型对 IGF1R 抑制敏感

Roberta L Beauchamp, Serkan Erdin, Luke Witt, Justin T Jordan, Scott R Plotkin, James F Gusella, Vijaya Ramesh

A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma

小脑桥脑角小鼠模型,用于研究 NF2 相关前庭神经鞘瘤的肿瘤生物学、听力和神经功能

Jie Chen, Lukas D Landegger, Yao Sun, Jun Ren, Nir Maimon, Limeng Wu, Mei R Ng, John W Chen, Na Zhang, Yingchao Zhao, Xing Gao, Takeshi Fujita, Sylvie Roberge, Peigen Huang, Rakesh K Jain, Scott R Plotkin, Konstantina M Stankovic, Lei Xu1

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

舒尼替尼治疗复发性和进展性非典型及间变性脑膜瘤的 II 期临床试验

Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic, Andrew Norden, Jan Drappatz, Eudocia Quant Lee, Benjamin Purow, Scott R Plotkin, Tracy Batchelor, Lauren E Abrey, Antonio Omuro

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

每月一次帕瑞肽 LAR(SOM230C)治疗复发性或进行性脑膜瘤的 II 期研究

Andrew D Norden, Keith L Ligon, Samantha N Hammond, Alona Muzikansky, David A Reardon, Thomas J Kaley, Tracy T Batchelor, Scott R Plotkin, Jeffrey J Raizer, Eric T Wong, Jan Drappatz, Glenn J Lesser, Sam Haidar, Rameen Beroukhim, Eudocia Q Lee, Lisa Doherty, Debra Lafrankie, Sarah C Gaffey, Mary Ger